本发明属于生物化学中的多肽药物技术领域。
The present invention belongs to the field of polypeptide medicine technology in biochemistry.
本发明属于生物技术制药工业中的基因工程生产多肽药物的技术领域。
The present invention belongs to the technology of gene engineering to produce polypeptide medicine.
转铁蛋白作为一种药物载体，在蛋白多肽药物的口服给药领域有着美好前景。
The utilization of transferrin as a carrier in peptide and protein peroral drug delivery is a promising approach.
本文概述了近年来转铁蛋白在蛋白多肽药物口服给药中的作用及有关转运机制的研究进展。
In this paper, the progress of transferrin applied in protein and peptide peroral delivery is reviewed, and the transportation mechanism of transferrin is also discussed.
CBLB502是一种多肽药物，它来源于沙门氏菌鞭毛蛋白的一部分，结合并有效地激活tlr5。
CBLB502 is a polypeptide drug derived from a portion of Salmonella flagellin that binds to and potently activates TLR5.
通常情况下，蛋白质和多肽药物被贮存在低温条件，甚至十被冻干成为固体形态，以期获得理想的效期。
They usually have to be stored under cold conditions or even freeze-dried to a solid form to achieve an acceptable shelf life.
“你刚才放多肽药物与细菌在一起并且粘它到细菌上，”从事研究的Sean Nair在电话采访中说。
"You just put the peptide drug together with the bacteria and it sticks to the bacteria," Sean Nair, who worked on the study, said in a telephone interview.
从骨组织Sialoprotein 中衍生的可与骨胶原结合的多肽药物，具促进骨组织修补和再生的功能。
A suite of proprietary collagen-binding peptides derived from bone sialoprotein (BSP) that are effective in promoting bone repair and regeneration.
翰宇生物是专业从事多肽系列产品研究、开发和生产的高新技术企业，是专业化的多肽原料与多肽药物生产基地。
Hybio is one of the state's leading groups specializing in peptide APIs and peptide drug in industrial scale manufacturing. It is a professional manufacturing base of peptide APIs and peptide drugs.
结果与结论该方法特异性、线性及线性范围、灵敏度、重现性、回收率均可达到蛋白多肽药物药代动力学研究的要求。
Results and Conclusion The specificity, linear range, reproducibility and recovery for the method could meet the requirements for studying pharmacokinetics of bioactive proteins or peptides.
而类脂多肽将在提高药物输送系统效率方面起到重要作用。
Here these designer lipid-like peptides may play a key role in improving effective drug delivery systems.
一种药物是基于他称作mitochines的多肽链研发的，它在普通人群中随着年龄增长而减少，但在百岁老人中减少有限。
One drug is based on a line of peptides he calls mitochines, which decrease with age in the normal population, but not as much among centenarians.
比起使用没加多肽的药物是非常强劲的速度了。
This was a far more powerful rate than using the drug without added peptides.
研究人员正在探索能否利用我们了解的这些免疫抑制多肽去开发治疗自身免疫性疾病的药物。
The investigators are currently exploring whether insights derived from understanding the potency of these immunosuppressive peptides can be exploited to treat autoimmune diseases.
简要介绍几种天然药物中存在的毒蛋白，多肽和氨基酸类化合物。
To review the study progresses in venom protein, peptide and amino acids in natural drug.
研究工作丰富了蛋白多肽类药物的缓释给药系统研究内容，具有较大的理论意义与实用价值。
This kind of study has fairly high academic significance and reference values to research the sustained-release preparation of protein or polypeptide drug.
心钠素是由28个氨基酸组成的多肽，是一种安全有效、具有良好应用前景的新型药物。
Atrial natriuretic peptide is a 28-amino-acid polypeptide, is one kind of new secure and effective, has the good application prospect medicine.
与小分子的化学药物相比，蛋白质和多肽的特点是在相对较低的浓度下就有较高的特异性和活性。
In comparison with small chemical drugs, protein and peptide pharmaceuticals have high specificity and activity at relatively low concentrations.
在研究中，结合多肽的药物和光线可以杀死1000万葡萄球菌细胞的99.97%。
In the study, the combination of the drug, the peptides and the light killed 99.97 percent of 10 million MRSA cells.
扼要介绍重组蛋白多肽类药物的临床药代动力学研究的内容、方法和特点。
The clinical pharmacokinetics on recombinant protein or peptides, including the methodology, contents, and characteristics were introduced in brief.
对不同的18F标记试剂、放射性氟化技术及18F标记多肽的药物动力学特征也进行了叙述。
In addition, different 18F labeling reagents, radiofluorination techniques and pharmacokinetics of 18F-labelled bioactive peptides are described.
结果与结论多肽、蛋白质药物缓释微球在药学领域有着广阔的发展前景。
Results and Conclusions Polypeptide-protein microspheres have broad prospects in the pharmaceutical filed.
将具有特殊生理功能的多肽作为基因或药物载体、或用于药物修饰等，可以提高基因转染效率，增强药物的靶向治疗效果，降低药物的毒副作用。
Due to the specific bioactivity of peptides, peptide-based gene and drug delivery systems could achieve improved gene transfection efficiency, enhanced drug targeting property and reduced side-effect.
多肽是当前引人注目的一类药物运输工具。
所述药物组合物包含磷脂酶(PL)多肽和蛋白转导结构域(PTD)的缀合物。
The pharmaceutical compositions contain a conjugate of a phospholipase (PL) polypeptide and a protein transduction domain (PTD).
制备过程温和，不需要高温和高速剪切力等剧烈条件，可保证多肽类药物的生物活性。
The mild preparation process without high temperature, high speed shearing and other intense condition can ensure the bioactivity of the polypeptide medicine.
制备过程温和，不需要高温和高速剪切力等剧烈条件，可保证多肽类药物的生物活性。
The mild preparation process without high temperature, high speed shearing and other intense condition can ensure the bioactivity of the polypeptide medicine.
应用推荐